Lithuania’s Biotech Industry

Leading Innovation
in Life Sciences

Explore: Lithuania’s Biotech Industry Explore: Lithuania’s Biotech Industry

Key areas of focus
Why Lithuania
Already here
Reports & Publications
News & Events
Contact us

Explore: Lithuania’s Biotech Industry Explore: Lithuania’s Biotech Industry

Key areas of focus
Why Lithuania
Already here
Reports & Publications
News & Events
Contact us

Lithuania stands at the forefront of biotechnology innovation with a rich 50-year history and cutting-edge advancements in precision medicine, biomanufacturing, and more. The country’s integrated network of science valleys and educational institutions fuels a rapidly growing ecosystem, making Lithuania a strategic location for biotech investments.

3rd

among OECD countries for biotechnology R&D spending intensity (as % of value added)

Source: Labiotech, 2024
92%

of all pharmaceutical and healthcare products manufactured in Lithuania are exported, with products going to over 100 countries

Source: Innovation Agency Lithuania, 2023
~2.7%

of Lithuania‘s GDP is generated by the Life Sciences sector

Source: LithuaniaBIO, 2023

Key Areas of Focus
in Lithuanian Biotechnology

Personalized Medicine

Cell and Gene Therapies

Lithuania is a recognized leader in cell and gene therapies, with significant contributions to global scientific research, including partnerships with the European Molecular Biology Laboratory (EMBL) and achievements such as the Kavli Prize in the CRISPR-Cas9 field. The country’s robust R&D environment supports the next generation of advanced therapeutics.

Health Data

Lithuania’s burgeoning tech sector is propelling forward AI-driven healthcare solutions, backed by a remarkable ICT talent pool and comprehensive, readily available health data for research and industry applications. As one of the first countries to establish a one-stop-shop data agency, Lithuania offers private companies streamlined access to centralized, high-quality health data for secondary use. Electronic health records system was developed 20 years ago and is aligned with European Health Data Space (EHDS) framework, adhering to the HL7 FHIR and SNOMED CT standards.

Biomanufacturing

AgTech and Novel Food Key local industry players

Industrial Biotechnology Key local industry players

Biologics

Home to leading biotech companies, including global giants like Thermo Fisher Scientific and Teva, Lithuania excels in biologics and personalized medicine. The upcoming BioCity campus, Europe’s largest biotech hub with a planned investment of 7 billion euros, is set to revolutionize the sector with state-of-the-art facilities, including those for cell and gene manufacturing and 3D bioprinting.

AgTech and Novel Food

Building on a strong agricultural heritage, Lithuania is pioneering sustainable and innovative farming and novel food production techniques. The rise of alternative protein sources, vertical farming, and functional food underscores the country’s commitment to eco-friendly and efficient food supply chains.

Industrial Biotechnology

Lithuania holds a unique position in synthetic biology, driving transformative advancements in the industrial manufacturing sector. This expertise facilitates the production of diverse biomaterials, including enzymes and amino acids, catering to industries such as chemicals, fast-moving consumer goods (FMCG), cosmetics, and materials. By prioritizing advanced fermentation technologies, Lithuania lays a strong foundation for businesses eager to leverage biological science for sustainable progress. For companies like Roquette, the availability of diverse raw materials has enabled significant expansion of their product range and business growth.

Why Invest in Lithuania’s
Biotechnology Industry?

Skilled and Innovative Workforce

Lithuania boasts one of the highest rates of STEM graduates in Europe, with a significant focus on biotechnology and biomedical sciences. The country’s education system is closely aligned with industry needs, ensuring a steady supply of highly skilled professionals. Lithuanian teams have excelled in the iGEM (International Genetically Engineered Machine) competition, achieving 2 Grand Prixs and securing all gold medals since their first participation in 2015.

1st in the EU

The most educated population in the EU, with the highest percentage having completed at least upper secondary education

Source: Eurostat, 2023
1st in the EU

The largest share of women in science and tech in the EU

Source: Eurostat, 2022
13

Higher education institutions offering Life Sciences-related programmes

Source: National Agency for Education, 2024

Unparalleled Governmental Support and Financial Incentives in Lithuania illustration

Lithuanian Government Support and Strategic Initiatives

Recognized as a priority industry, biotechnology benefits from significant government support, including incentives for R&D and streamlined regulatory processes. Lithuania’s national biotechnology strategy aims to double the sector’s contribution to the GDP by 2030.

European Medicines Agency regulations apply
Mutual Recognition Agreement with the US FDA
Hospital exemptions for administering ATMPs in clinical trials (in case of high unmet medical need)

Unlock the benefits of Lithuania’s Green Corridor for biotechnology investments

The Green Corridor initiative fast-tracks large-scale investment projects with 0% corporate tax for 20 years, streamlined planning, and faster decision-making from public authorities, ensuring smoother setup and long-term success.

Explore the benefits

Integrated Value Chain

Lithuania offers comprehensive support across the entire biotech value chain.

Research

10 Science Valleys to initiate R&D processes and pilot your ideas.

Access to data

Lithuania is one of the few countries in the EU, whose national regulation allows private companies to access patient data for secondary use via a streamlined process, combined with centralized population and other data.

Clinical development

5 clinical hospitals facilitate extensive clinical trials, ranging from pre-clinical to Phase III.

Manufacturing

From small-scale brownfield solutions in industry-focused innovation parks to free economic zones, there is a dynamic spectrum of tailored environments for industrial growth and biomanufacturing.

Logistics

Upon reaching commercial states, biotech products benefit from the country’s efficient logistics network. Over 90% of all life sciences products are exported to major markets like the USA, Germany, Asia.

Cost-Effective European Hub

Offering competitive costs compared to Western Europe, Lithuania provides a cost-effective base with access to high-quality talent and advanced technologies, making it an attractive location for biotechnology firms.

Annual labour costs at a Biotech facility in Europe
```
Source: fDi Benchmark by FT, 2024
```
Annual labour costs at a Biotech facility Worldwide
```
Source: fDi Benchmark by FT, 2024
```

Biotechnology Companies in Lithuania

Local innovators:

Founded by Professor V. Šikšnys, winner of the Kavli Prize, Caszyme provides CRISPR-Cas9 applications for various companies in the US and Asia.
Biomatter work at the intersection of synthetic biology and AI, developing technologies for generative protein design and experimental tools for the collection of biological data.
Droplet Genomics designs microfluidic instruments, consumables, and data analysis tools, which allow biological samples to be analyzed at the granularity of single cells.
Focused on AgTech, Nando is developing high-value microbiological products and chemical additives, offering sustainable alternatives to traditional products.

With extensive expertise in drug substance and drug product development, as well as GMP-compliant manufacturing, Northway is well-versed in all aspects of the biopharmaceutical value chain.
A one-stop-shop clinical research organization operating in Europe, CIS, EAEU, MENA, LATAM and the US, Biomapas caters to biopharmaceutical and medical device companies.
Auga Group specializes in sustainable agriculture, from organic produce and feedstock to innovative agriculture machinery.
Committed to circularity, and sustainable processes, Divaks creates high-quality insect-derived ingredients, primarily proteins and oils.

Want to learn more about biotechnology opportunities?

Lithuania has a lot to offer, and we’re here to help you discover it. At Invest Lithuania, our team is here to make your business journey smoother. From connecting you with the right people to accessing valuable resources, we take care of the details so you can drive your business forward.